TNF and rheumatoid arthritis: Traditional non-steroidal anti-inflammatory medicines (NSAIDs) and disease-modifying anti-rheumatic drugs (DMARDs) have been replaced by innovative biological agents such as TNF monoclonal antibodies, which have improved the treatment strategies for RA patients in recent years (Ben Mrid et al., 2022).